C-Reactive Protein and Electrocardiographic ST-Segment Depression Additively Predict Mortality
The Strong Heart Study
Peter M. Okin, MD, FACC*,*,
Mary J. Roman, MD, FACC*,
Lyle G. Best, MD ,
Elisa T. Lee, PhD ,
James M. Galloway, MD, FACC ,
Barbara V. Howard, PhD|| and
Richard B. Devereux, MD, FACC*
* Division of Cardiology, Department of Medicine, Weill Medical College of Cornell University, New York, New York
Missouri Breaks Industries Research Inc., Timber Lake, South Dakota
College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
University of Arizona, Tucson, Arizona
|| MedStar Research Institute, Washington, DC
View larger version (17K):
[in a new window]
|
Figure 1 Kaplan-Meier plots of cumulative cardiovascular mortality (A) and all-cause mortality (B) according to the magnitude of ST-segment depression (STD) partitioned at 50 µV.
|
|
View larger version (17K):
[in a new window]
|
Figure 2 Kaplan-Meier plots of cumulative cardiovascular mortality (A) and all-cause mortality (B) according to high-sensitivity C-reactive protein (CRP) partitioned at 7.0 mg/l.
|
|
View larger version (19K):
[in a new window]
|
Figure 3 Kaplan-Meier plots of cumulative cardiovascular mortality (A) and all-cause mortality (B) according to combined ST-segment depression (STD) and high-sensitivity C-reactive protein (CRP) criteria. (STD–/CRP– represents both negative; STD+ or CRP+ represents either positive; STD+/CRP+ represents both positive).
|
|
|
